Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL191380 | 1.00 | KDM4E (0.43) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL28736283 | 0.88 | KDM4E (0.36) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL19467704 | 0.81 | KDM4E (0.41) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL11330514 | 0.80 | KDM4E (0.40) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL9644755 | 0.79 | KDM4E (0.44) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL136620 | 0.77 | KDM4E (0.38) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL136619 | 0.77 | KDM4E (0.38) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL8038765 | 0.75 | KDM4E (0.37) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL8038766 | 0.75 | KDM4E (0.37) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL13346475 | 0.75 | KDM4E (0.37) | KDM4EALDH1A1MEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150566-A1 | HEAT-RESISTANT EPDM COMPOSITION, AND ASSOCIATED FORMULATION METHOD AND PARTS | THE TORONTO-DOMINION BANK, AS AGENT (CA) | 2024-05-09 | — | — | US | claimed |
| WO-2024047583-A1 | PREPARATION OF SILANE-GRAFTED EPDM AND MOISTURE CURING THEREOF | AIRBOSS OF AMERICA CORP. (CA) | 2024-03-07 | — | — | WO | claimed |
| EP-4305102-A1 | HEAT-RESISTANT EPDM COMPOSITION, AND ASSOCIATED FORMULATION METHOD AND PARTS | Airboss of America Corp. (CA) | 2024-01-17 | — | — | EP | claimed |
| EP-3197881-B1 | DIAZIRINE COMPOUNDS AS PHOTOCROSSLINKERS AND PHOTOIMAGEABLE COMPOSITIONS COMPRISING THEM | PROMERUS LLC (US) | 2020-04-29 | — | — | EP | claimed |
| US-10303060-B2 | Diazirine compounds and compositions derived therefrom | PROMERUS, LLC (US) | 2019-05-28 | — | — | US | claimed |
| US-20180186747-A1 | DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM | PROMERUS, LLC (US) | 2018-07-05 | — | — | US | claimed |
| US-9938241-B2 | Diazirine compounds and compositions derived therefrom | PROMERUS, LLC (US) | 2018-04-10 | — | — | US | claimed |
| US-20160147145-A1 | PHOTOIMAGEABLE COMPOSITIONS CONTAINING OXETANE FUNCTIONALITY | PROMERUS, LLC | 2016-05-26 | — | — | US | claimed |
| US-20160083352-A1 | DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-03-24 | — | — | US | claimed |
| EP-0298408-B1 | METHOD FOR PREPARING NORBORNENE STRUCTURE COMPOUND | NIPPON OIL CO. LTD. (JP) | 1991-12-18 | — | — | EP | claimed |
| US-4017669-A | COORDINATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | claimed |
| EP-4695332-A1 | RUBBER COMPOSITION, AND ASSOCIATED FORMULATION METHOD AND PARTS | Airboss of America Corp. (CA) | 2026-02-18 | — | — | EP | disclosed |
| EP-4581064-A1 | PREPARATION OF SILANE-GRAFTED EPDM AND MOISTURE CURING THEREOF | Airboss of America Corp. (CA) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024214043-A1 | RUBBER COMPOSITION, AND ASSOCIATED FORMULATION METHOD AND PARTS | AIRBOSS OF AMERICA CORP. (CA) | 2024-10-17 | — | — | WO | disclosed |
| US-20240150566-A1 | HEAT-RESISTANT EPDM COMPOSITION, AND ASSOCIATED FORMULATION METHOD AND PARTS | THE TORONTO-DOMINION BANK, AS AGENT (CA) | 2024-05-09 | — | — | US | disclosed |
| US-4770782-A | Method for preventing gel/emulsion formation | EXXON CHEMICAL PATENTS INC. (US) | 1988-09-13 | — | — | US | disclosed |
| EP-0202060-A1 | Use of silicate as chain branching suppressor in EPDM production | EXXON CHEMICAL PATENTS INC. (US) | 1986-11-20 | — | — | EP | disclosed |
| US-4093583-A | WITH AN ALPHA-OLEFIN AND A NONCONJUGATED DIENE, CURING AGENT, ACTIVATOR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-06-06 | — | — | US | disclosed |
| US-4017669-A | COORDINATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-4016349-A | SOLVENT EXTRACTION, SOLID SUPPORT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083352-A1 | DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM | RDX, AOX1, ALDH1A2 | KDM4E 2719/4885ALDH1A1 24/4885MEN1 3151/4885 |
| US-20180186747-A1 | DIAZIRINE COMPOUNDS AND COMPOSITIONS DERIVED THEREFROM | ZYX, AOX1, RDX | KDM4E 1745/4885ALDH1A1 145/4885MEN1 2280/4885 |
| US-10303060-B2 | Diazirine compounds and compositions derived therefrom | ZYX, AOX1, RDX | KDM4E 1745/4885ALDH1A1 145/4885MEN1 2280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.